The goal of BBI’s SeqFirst project is to determine whether conducting whole genome sequencing (WGS) as soon as children are suspected of having health problems is effective than assessing children through conventional testing and referrals to multiple specialists.

SeqFirst involves two different populations: infants admitted to a neonatal intensive care unit and children recently been diagnosed with developmental differences.

The results of the study will provide guidance about the best ways to use whole genome sequencing in helping families of children with health conditions find precise genetic diagnoses, better anticipate children’s clinical needs, and utilize new treatments.

Lean more at: https://www.seqfirst.org/